Furukawa Yoshio | Division Of Coronary Artery Disease Department Of Internal Medicine Hyogo College Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-682 The Optimal Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stenting(PJ115,Thromboembolism/Antithrombotic Therapy/Thrombolysis (IHD),Poster Session (Japanese),The 73rd Annual Scientifi
PJ-642 Prediction of Development of Atrial Fibrillation in Patients With Chronic Heart Failure by Atrial Late Potential and Chronic Kidney Disease(PJ108,Heart Failure (Laboratory/Biomarkers) 1 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeti
PJ-505 Reduced Renal Function, Repeated Heart Failure Hospitalization and Body Weight Loss Predict Cardiac Death in Decompensated Systolic Heart Failure(PJ085,Heart Failure (Pathophysiology) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting
PJ-422 Omega-3 Fatty Acids Provide More Beneficial Effects for Atrial Late Potential than Statins in Patients with Atrial Arrhythmias and Dyslipidemia(PJ071,ECG/Body Surface Potential Mapping/Holter 1 (A),Poster Session (Japanese),The 73rd Annual Scientif
PJ-362 Abnormal Myocardial Fatty Acid Metabolism might Predict Adverse Outcome in Patients with Permanent Right Ventricular Apex Pacing : a Prospective Study(PJ061,Nuclear Cardiology (Coronary, Myocardium) 2 (I),Poster Session (Japanese),The 73rd Annual S
DPJ-017 Kidney Enhancement Following Percutaneous Coronary Intervention Predicts Contrast-Induced Nephropathy(DPJ03,Kidney/Renal Circulation/CKD (H),Digital Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OJ-242 Oxidized Low-Density Lipoprotein Levels is a Good Predictor of the Response to Atorvastatin Therapy in Patients with Chronic Heart Failure(OJ41,Heart Failure (Treatment) (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Jap
Sodium Bicarbonate Improves Long-Term Clinical Outcomes Compared With Sodium Chloride in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
PJ-509 Atorvastatin Might Improve Intra-atrial Conduction Disturbance in Patients With Chronic Heart Failure by the Antioxidative Effect : a Prospective Study(Heart failure, clinical(17)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of th
PJ-323 Elevated BUN Level and Repeated Heart Failure Hospitalization Predict Cardiac Death in Patients Admitted for Decompensated Heart Failure(Heart failure, clinical(16)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
PJ-153 Clinical Implication of Subclinical Hypothyroidism and Cardiac l-123 Metaiodobenzylguanidine Imaging for Risk Stratification of Poor Outcome in Chronic Heart Failure(Nuclear cardiology(07)(I),Poster Session(Japanese),The 72nd Annual Scientific Meet
Chylomicron Remnants Stimulate Release of Interleukin-1β by THP-1 Cells
PJ-123 Urine 8-iso Prostaglandin F_2α is a useful Marker for Oxidative Stress in Hypertension(Hypertension, Clinical 3 (H) : PJ21)(Poster Session (Japanese))
The Renin-Angiotensin System Is Involved in the Production of Plasminogen Activator Inhibitor Type 1 by Cultured Endothelial Cells in Response to Chylomicron Remnants
Chylomicron Remnants Stimulate Interleukin (IL)-1β but Not IL-18 Production in THP-1 Macrophages
Circulating Plasma Levels of Interleukin 18 in Patients with Acute Coronary Syndrome
Effects of Renin-Angiotensin System in Production of Plasminogen Activator Inhibitor Type1 by Cultured Endothelial Cells in Response to Chylomicron Remnants
Troglitazone Reduces Activity of the NA^+/H^+ Exchanger in Fructose-Fed Borderline Hypertensive Rats
Changes of Plasma 8-Isoprostaglandin F2 α (8-ISO), 8-Hydroxy-2'-Deoxyguanosine(8-OHdG), and Malondialdehyde -Modified- LDL(MDA-LDL) After Percutaneous Coronary Intervention for Acute Myocardial Infarction
The characteristics of intracoronary thrombus by Rescue thrombectomy
PE-019 The Effect of Beta-adrenergic Stimulation and Blockade on the Spatio-temporal Dispersion of Atrial Repolarization and Atrial Fibrillation(Arrhythmia, diagnosis/pathophysiology/EPS-6 (A) PE4,Poster Session (English),The 70th Anniversary Annual Scien
Discordant Repolarization Alternans-Induced Atrial Fibrillation is Suppressed by Verapamil
The Circadian Variation of Temporal QT Interval Dispersion in Right Precordial Leads in Brugada Syndrome (ECG/Body Surface Potential Mapping/Holter 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Discordant Alternans of Repolarization in Atrium Initiates Atrial Fibrillation and Is Suppressed by Verapamil
Circadian Variation of Beat-To-Beat QT Interval Variability in Patients with Prior Myocardial Infarction
Wavelet Transform Analysis of Heart Rate Variability to Assess the Autonomic Changes Associated With the Onset of Paroxysmal Atrial Fibrillation
PE-360 Na Channel Blocker Enhances Temporal QT Interval Dispersion in Right Precordial Leads in Brugada Syndrome(ECG/Body Surface Potential Mapping/Holler 7 (A) : PE62)(Poster Session (English))
PE-237 Features of Cardiac Sympathetic Nerve Distribution in the Brugada Syndrome.(Nuclear Cardiology 8 (I) : PE41)(Poster Session (English))
PE-224 Circadian Variation of Beat-to-Beat QT Interval Variability in Patients With Prior Myocardial Infarction(ECG/Body Surface Potential Mapping/Holter 4 (A) : PE39)(Poster Session (English))
OJ-372 Circadian Expression of Plasminogen Activator Inhibitor-1 (PAI-1) in Angiotensin II Type1a Receptor Knockout Mice(Thromboembolism/Thrombolysis 3 (IHD) : OJ45)(Oral Presentation (Japanese))
OE-111 RhoA and Rho-kinase are involved in Interleukin (IL)-18-induced gene expression and apoptosis in cardiac myocytes(Heart Failure, Basic 1 (M) : OE13)(Oral Presentation (English))
PJ-356 p300 and Serum Response Factor are involved in RhoA-, and Rho-kinase-mediated c-fos, b-MHC and ANP gene expression in cardiac myocytes(Molecular Biology, Myocardium 1 (M) : PJ60)(Poster Session (Japanese))
p300 Is Involved in Rho-and Rho Kinase-Mediated C-fos Gene Expression in Cardiac Myocytes
OE-323 Ultrasound enhances retrovirus-mediated gene transfer in vivo and in vitro(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English))

もっと見る

スポンサーリンク